Inventure
Southbury, US · Delaware LLC · 8 known investors
Biotech
Founders & leadership
KS
Kyle SalemExecutive
BD
Bill DoyleExecutive
JB
Jonathan BalfourExecutive
RR
Richard RoseneExecutive
Board
BR
Brad RummerBoard director
RD
Richard DeslauriersBoard director
Investors · 8
Balderton CapitalreportedLondon · $5M – $50M
CDP Venture CapitalreportedRome
FELIX CAPITALreportedLondon · $1M – $20M
MetaplanetreportedTallinn · $500K – $10M
Passion CapitalreportedLondon
Stena Sessanreported
Superhero CapitalreportedHelsink · $50K – $1M
Union Square Ventures (USV)reportedNew York City · $1M – $8M
Reported raises · per SEC filings
Form D private placements$6M disclosed across 11 rounds · 2015–2026
▶$200KraisedFeb 2026 · 4 investors · PharmaceuticalsRule 506(b)
▶$200KraisedFeb 2026 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard DeslauriersDirector
- Offering amount
- $200K
- Amount sold
- $200K
- Minimum investment
- $50K
- First sale
- Feb 2026
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$361.5KraisedJul 2025 · 6 investors · PharmaceuticalsRule 506(b)
▶$361.5KraisedJul 2025 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kyle SalemExecutive Officer
- Brad RummerDirector
- Richard DeslauriersDirector
- Offering amount
- $361.5K
- Amount sold
- $361.5K
- Minimum investment
- $10K
- First sale
- Jul 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$250KraisedAug 2023 · 5 investors · PharmaceuticalsRule 506(b)
▶$250KraisedAug 2023 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard J DeslauriersDirector
- Offering amount
- $250K
- Amount sold
- $250K
- Minimum investment
- $25K
- First sale
- Jul 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedMar 2023 · 5 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedMar 2023 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard J DeslauriersDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- Minimum investment
- $25K
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1MraisedSep 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$1MraisedSep 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard J DeslauriersDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- First sale
- Sep 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$45KraisedJan 2021 · 8 investors · PharmaceuticalsRule 506(b)
▶$45KraisedJan 2021 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard J DeslauriersDirector
- Brad RummerDirector
- Offering amount
- $45K
- Amount sold
- $45K
- Minimum investment
- $45K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$350KraisedMar 2020 · 9 investors · PharmaceuticalsRule 506(b)
▶$350KraisedMar 2020 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert F. JacobsExecutive Officer
- Richard J. DeslauriersDirector
- Brad RummerDirector
- Offering amount
- $500K
- Amount sold
- $350K
- Minimum investment
- $50K
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$175KraisedOct 2019 · 7 investors · PharmaceuticalsRule 506(b)
▶$175KraisedOct 2019 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert F. JacobsExecutive Officer
- Richard J. DeslauriersDirector
- Brad RummerDirector
- Offering amount
- $250K
- Amount sold
- $175K
- Minimum investment
- $25K
- First sale
- Oct 2019
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Inventure's investors?
- Inventure's investors include Balderton Capital, CDP Venture Capital, FELIX CAPITAL, Metaplanet, Passion Capital, Stena Sessan, Superhero Capital, Union Square Ventures (USV).
- How much funding has Inventure raised?
- Inventure has disclosed $6M raised across 11 rounds.
- Where is Inventure headquartered?
- Inventure is headquartered in Southbury, US.



